The mutation appears to cause ALS and FTD through loss of function due to reduced C9ORF72 protein expression and/or gain of toxic function due to the aggregation of RNA and dipeptide repeat proteins [153]. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.